(Q72150505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

meta-analysis

0 references

title

Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients. A meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

chronic heart failure

1 reference

P Nony

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

J P Boissel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M Lievre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

A Leizorovicz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M C Haugh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

S Fareh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

B de Breyne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

191-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00192547

24 October 2019

exact match

0 references

cites work

A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group

1 reference

12 December 2020

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

1 reference

12 December 2020

Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions

1 reference

12 December 2020

Long-term oral enoximone therapy in chronic cardiac failure

1 reference

12 December 2020

Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials.

1 reference

12 December 2020

Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors

1 reference

12 December 2020

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

12 December 2020

Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study

1 reference

12 December 2020

Acute positive inotropic intervention: the phosphodiesterase inhibitors

1 reference

12 December 2020

Effect of drug therapy on survival in chronic congestive heart failure

1 reference

12 December 2020

Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine

1 reference

12 December 2020

Clinical trial methodology

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

Inotropic therapy for heart failure--an unfulfilled promise

1 reference

12 December 2020

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Non-receptor-mediated inotropic drugs

1 reference

12 December 2020

Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Obtaining medically meaningful answers from an overview of randomized clinical trials.

1 reference

12 December 2020

Vasodilator therapy for chronic heart failure

1 reference

12 December 2020

Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion

1 reference

12 December 2020

The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat.

1 reference

12 December 2020

Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure

1 reference

12 December 2020

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

12 December 2020

Some Thoughts on Clinical Trials, Especially Problems of Multiplicity

1 reference

12 December 2020

A comparison of statistical methods for combining event rates from clinical trials

1 reference

12 December 2020

Clinical results with oral milrinone in heart failure

1 reference

12 December 2020

Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs

1 reference

12 December 2020

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Cyclic AMP and the pathogenesis of myocardial injury

1 reference

12 December 2020

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

1 reference

12 December 2020

Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

1 reference

12 December 2020

Myocardial degeneration in mice treated with dibutyryl cyclic AMP and/or theophylline

1 reference

12 December 2020

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

12 December 2020

The search for the ideal positive inotropic agent

1 reference

12 December 2020

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

12 December 2020

Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo controlled trial

1 reference

12 December 2020

Vasodilator therapy of cardiac failure (second of two parts).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00192547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070498%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference